基本信息
views: 92
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
The focus of our research for the past decade has been the development of treatment strategies to modulate the immune system of patients with cancer. These efforts are based on studies of patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) for hematologic malignancies. Although allogeneic transplantation can cure a proportion of these individuals, success is limited by transplant-related complications such as graft-versus-host disease (GVHD). It has long been recognized that T lymphocytes from the donor marrow play a pivotal role in the pathogenesis of GVHD. In patients undergoing HSCT, depleting donor marrow T cells with an antibody to a T cell surface structure results in a dramatic decrease in the incidence of GVHD. This approach also eliminates the need for immune-suppressive medications. These agents can be toxic, causing organ damage and increasing susceptibility to infection. Recently we have explored strategies to selectively infuse CD8+ depleted lymphocytes in hopes of prompting graft-versus-leukemia (GVL) activity without producing GVHD. We validated this strategy in a randomized trial of CD8-depleted donor lymphocyte infusions after T cell-depleted allotransplantation, and are now conducting further trials on CD8 depletion. While T cell depletion reduces GVHD, its effect on immune reactivity may lead to an increased risk of relapse of certain leukemias after transplantation. Preserving and restoring this GVL activity without compromising safety is a major thrust of our clinical and laboratory research.
Research Interests
Papers共 826 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Helena Kim,Rafia Ali,Samuel Short, Sarah Kaunfer, Shobana Krishnamurthy, Lavanya Durai,Osman Yilmam, Tushar Shenoy, Audrey E. Monson, Charlotte Thomas,Isabel Park,Dylan Martini,
Bone Marrow Transplantationno. 2 (2024): 178-188
bioRxiv the preprint server for biology (2024)
Katie Maurer,Cameron Y Park, Shouvik Mani, Mehdi Borji, Crystal Shin, Wesley Lu,Haoxiang Lyu, Domenic Abbondanza, Chanell Mangum, Sachi Krishna, Samouil Farhi,Shuqiang Li,
Transplantation and Cellular Therapyno. 2 (2024): S256-S257
BLOOD ADVANCESno. 4 (2024): 978-990
Nature Communicationsno. 1 (2024): 1-18
Roman M Shapiro,Haesook T Kim,Remy Dulery,Deborah Liney, Heather M Garrity, Kevin M Panaro, Chloe Au, Casey Gervais, Jessica S Little,Vincent T Ho, Corey S Cutler,John Koreth,
Blood advances (2024)
Jessica S. Little,Miranda S. Oakley, Anna R. Thorner,Demerise Johnston,Victoria Majam, Alexis D. Liakos,Lewis A. Novack, Hong Zheng,Scott Meredith,Chao-Kai Chou, Benjamin R. Newton,Robert J. Soiffer,
Mark J Levis,Mehdi Hamadani,Brent Logan,Richard J Jones, Anurag K Singh,Mark Litzow,John R Wingard,Esperanza B Papadopoulos,Alexander E Perl,Robert J Soiffer,Celalettin Ustun, Masumi Ueda Oshima,
Journal of clinical oncology : official journal of the American Society of Clinical Oncologypp.JCO2302474-JCO2302474, (2024)
TRANSPLANTATION AND CELLULAR THERAPYno. 2 (2024)
Anna Sureda,Paul A. Carpenter, Andrea Bacigalupo,Vijaya Raj Bhatt,Josu de la Fuente,Aloysius Ho,Leslie Kean,Jong Wook Lee,Isabel Sánchez-Ortega, Bipin N. Savani, Johannes Schetelig,Edward A. Stadtmauer,
Bone Marrow Transplantationno. 6 (2024): 1-6
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn